Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript February 15, 2024

Royalty Pharma plc beats earnings expectations. Reported EPS is $1.15, expectations were $1.01. RPRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Q4 2023 Earnings Conference Call. I would like now to turn the conference over to George Grofik, Senior Vice...